Medical devices, healthcare technology and the business of care
510(k) clearance · K262531

OnControl Powered Bone Access Systems;OnControl Bone Marrow Aspiration System;OnControl Bone Marrow Biopsy System;OnControl Bone Lesion Biopsy System;OnControl Power Driver

Teleflex Medical LLC · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONK262531

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 27, 2026 for Teleflex Medical, LLC's OnControl Powered Bone Access Systems, covering the Bone Marrow Aspiration System, Bone Marrow Biopsy System, Bone Lesion Biopsy System and Power Driver. The submission K262531 was received July 22, 2026 under 21 CFR 876.1075 (biopsy instrument, Class II, product code KNW). SESE is a 510(k) clearance, not a PMA approval.

The 510(k) summary lists K142377 as predicate and K070759 and K113872 as reference devices, and describes changes including added needle-set components and sizes, packaging modifications, printed circuit board and firmware changes, and updated performance specifications. Bench and biocompatibility testing is cited as support. The summary does not report clinical outcome data, and no post-market commitments or limitations are stated in the provided documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 27, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262531
Regulatory pathway
510(k) premarket notification
Product code
KNW
Decision code
SESE
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Instrument, Biopsy.

Product code
KNW
FDA device class
2

FDA decision timeline

  1. K262531 received

    Application receipt date recorded by FDA.

  2. K262531 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Teleflex Medical LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Morrisville, NC

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records